Connect with us

Health

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.ABSTRACTPURPOSE: The immunogenicity and…

Published

4 years ago

on

November 9, 2021

By

Noosa Online News Publisher

Article feature image

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.
ABSTRACT
PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood.
METHODS: We performed a prospective cohort…

Click here to view the original article.

Related Topics:Australia Docwirenews.com Featured

Australia discovers new solution to fight chronic middle ear infections – BSA bureau

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections – News-Medical.Net

Continue Reading

Advertisement

General24 hours ago

Mitchell Starc fires Ashes warning in Sheffield Shield return as Jake Weatherald and Beau Webster fail to fire

General23 hours ago

Global humanitarian Alison Thompson awarded 2026 Australian of the Year for NSW

Noosa News22 hours ago

The Brisbane state school with an IB program preparing students for university

General12 hours ago

Owners barred from Beachport holiday units after council fire safety change

About Us	Contact Us

© 2025 Noosa Online News
Privacy Policy